Comparability of Echographic and Tomographic Assessments of Body Fat Changes Related to the HIV Associated Adipose Redistribution Syndrome (HARS) in Antiretroviral Treated Patients

Ultrasound in Medicine and Biology

Volumn 34, Issue 7, 2008, Pages 1043-1048

  Gulizia, Rosario ^a   Vercelli, Alessandro ^a   Gervasoni, Cristina ^b   Uglietti, Alessia ^a   Ortu, Massimiliano ^b   Ferraioli, Giovanna ^a   Galli, Massimo ^b   Filice, Carlo ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Antiretrovirals; Body fat changes; HIV infection; Lipodystrophy; Ultrasonography

Indexed keywords

COLLOIDS; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC RADIOGRAPHY; FOOD PROCESSING; GELATION; HEALTH; IMAGING TECHNIQUES; MEDICAL IMAGING; PATIENT MONITORING; PINCH EFFECT; REGRESSION ANALYSIS; SKIN; THERMOGRAPHY (TEMPERATURE MEASUREMENT); TOMOGRAPHY; TRANSDUCERS;

ANTIRETROVIRALS; BODY FAT CHANGES; BODY FATS; COMPUTED TOMOGRAPHY; CT SCANNING; HIV INFECTION; LIPODYSTROPHY; METALLIC SKIN; REFERENCE POINTS; RELIABLE METHOD; STAND-OFF; TOMOGRAPHIC; ULTRASONOGRAPHY;

ELECTRIC INSTRUMENT TRANSFORMERS;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; BODY FAT; BODY FAT CHANGE; BODY FAT DISTRIBUTION; BRACHIAL LIPOATROPHY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CRURAL LIPOATROPHY; ECHOGRAPHY; FACIAL LIPOATROPHY; FEMALE; HIV ASSOCIATED ADIPOSE REDISTRIBUTION SYNDROME; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INTERMETHOD COMPARISON; LINEAR REGRESSION ANALYSIS; LIPOATROPHY; MALE; PRIORITY JOURNAL; RELIABILITY; STANDARDIZATION; STATISTICAL SIGNIFICANCE; SUBCUTANEOUS FAT; SUBCUTANEOUS FAT THICKNESS; TRANSDUCER;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY MASS INDEX; CD4 LYMPHOCYTE COUNT; FACE; FEMALE; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SUBCUTANEOUS FAT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 45949111105     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2007.12.010     Document Type: Article

References (30)

1. Asensi V., Martin-Roces E., Carton J.A., Collazos J., Maradona J.A., Alonso A., Medina M., Aburto J.M., Martinez E., Rojo C., Bustillo E., Fernandez C., and Arribas J.M. Perirenal fat diameter measured by echography could be an early predictor of lipodystrophy in HIV type 1-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis 39 (2004) 240-247
2. Asensi V., Martin-Roces E., Collazos J., Carton J.A., Maradona J.A., Alonso A., Medina M., Aburto J.M., Fernandez C., and Martinez E. Association between physical and echographic fat thickness assessments and a lipodystrophy grading scale in lipodystrophic HIV patients: Practical implications. AIDS research and human retroviruses 22 (2006) 830-836
3. Bogner J.R., Vielhauer V., Beckmann R.A., Michl G., Wille L., Salzberger B., and Goebel F.D. Stavudine versus zidovudine and the development of lipodystrophy. J Acquir Immune Defic Syndr 27 (2001) 237-244
4. Carey D., Wand H., Martin A., Rothwell S., Emery S., Cooper D.A., and Carr A. Evaluation of ultrasound for assessing facial lipoatrophy in a randomized, placebo-controlled trial. Aids 19 (2005) 1325-1327
5. Carr A. HIV lipodystrophy: Risk factors, pathogenesis, diagnosis and management. Aids 17 Suppl. 1 (2003) S141-S148
6. Carr A., and Law M. An objective lipodystrophy severity grading scale derived from the lipodystrophy case definition score. J Acquir Immune Defic Syndr 33 (2003) 571-576
7. Carr A., Samaras K., Burton S., Law M., Freund J., Chisholm D.J., and Cooper D.A. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. Aids 12 (1998) F51-F58
8. Cavalcanti R.B., Cheung A.M., Raboud J., and Walmsley S. Reproducibility of DXA estimations of body fat in HIV lipodystrophy: Implications for clinical research. J Clin Densitom 8 (2005) 293-297
9. Engelson E.S., Kotler D.P., Tan Y., Agin D., Wang J., Pierson Jr. R.N., and Heymsfield S.B. Fat distribution in HIV-infected patients reporting truncal enlargement quantified by whole-body magnetic resonance imaging. Am J Clin Nutr 69 (1999) 1162-1169
10. Friis-Moller N., Weber R., Reiss P., Thiebaut R., Kirk O., d'Arminio Monforte A., Pradier C., Morfeldt L., Mateu S., Law M., El-Sadr W., De Wit S., Sabin C.A., Phillips A.N., and Lundgren J.D. Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study. Aids 17 (2003) 1179-1193
11. Gellett L.R., Haddon L., and Maskell G.F. CT appearances of HIV-related lipodystrophy syndrome. Br J Radiol 74 (2001) 382-383
12. Grinspoon S., and Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 352 (2005) 48-62
13. Gripshover B, Tien PC, Saag M, Osmond D, Bacchetti P, Grunfeld C, for the Investigators of the Fat Redistribution and Metabolic Change in HIV Infection (FRAM) Study 2. Lipoatrophy is the dominant feature of the lipodystrophy syndrome in HIV-infected men. Program and Abstracts of the 10th Conference on Retroviruses and Opportunistic Infections; February 10-14, 2003; Boston, MA. Abstract 732.
14. Gulizia R., Brunetti E., Gervasoni C., Galli M., and Filice C. Sonographic assessment of lipodystrophy in HIV-infected patients: Some open questions. Clin Infect Dis 40 (2005) 323-324 author reply 24-25
15. Gulizia R., Vercelli A., Gervasoni C., Ortu M., Calliada F., Troia G., Galli M., and Filice C. Controversy concerning role of ultrasonographic lipoatrophy assessments in HIV patients. Aids 20 (2006) 789-790
16. Hadigan C., Meigs J.B., Wilson P.W., D'Agostino R.B., Davis B., Basgoz N., Sax P.E., and Grinspoon S. Prediction of coronary heart disease risk in HIV-infected patients with fat redistribution. Clin Infect Dis 36 (2003) 909-916
17. Lichtenstein K., Balasubramanyam A., Sekhar R., and Freedland E. HIV-associated adipose redistribution syndrome (HARS): Definition, epidemiology and clinical impact. AIDS Res Ther 4 (2007) 16
18. Lichtenstein K.A. Redefining lipodystrophy syndrome: Risks and impact on clinical decision making. J Acquir Immune Defic Syndr 39 (2005) 395-400
19. Mallon P.W., Miller J., Cooper D.A., and Carr A. Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy. Aids 17 (2003) 971-979
20. Martinez E., Bianchi L., Garcia-Viejo M.A., Bru C., and Gatell J.M. Sonographic assessment of regional fat in HIV-1-infected people. Lancet 356 (2000) 1412-1413
21. Milinkovic A, Vidal S, Bianchi L, Ayuso C, Domingo P, Gomila M, Gatell JM, Martinez E. Comparative assessment of objective methods for the measurement of body fat. 5th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. July 8-11 2003, Le Meridien Montparnasse, Paris, France. Antiviral Therapy 2003;8:L63 (Abstract 92).
22. Muurahainen N., Pettit R., Kotler D., Falutz J., Santos G., Kleintop M., and Glesby M. Abnormalities in HIV-associated lipodystrophy syndrome that vary by weight status. [Abstract 63]. Program and Abstracts of the 1st International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV (1999) 53 San Diego, CA
23. Padilla S., Gallego J.A., Masia M., Ardoy F., Hernandez I., and Gutierrez F. Ultrasonography and anthropometry for measuring regional body fat in HIV-infected patients. Current HIV Res 5 (2007) 459-466
24. Padilla S., Gallego J.A., Masia M., and Gutierrez F. Single-slice computed tomography and anthropometric skinfold analysis for evaluation of facial lipoatrophy in HIV-infected patients. Clin Infect Dis 39 (2004) 1848-1851
25. Palacios R., Galindo M.J., Arranz J.A., Lozano F., Estrada V., Rivero A., Morales D., Asensi V., del Arco A., Munoz A., and Santos J. Cervical lipomatosis in HIV-infected patients: A case-control study. HIV Med 8 (2007) 17-21
26. Piliero P.J., Hubbard M., King J., and Faragon J.J. Use of ultrasonography-assisted liposuction for the treatment of human immunodeficiency virus-associated enlargement of the dorsocervical fat pad. Clin Infect Dis 37 (2003) 1374-1377
27. Schambelan M., Benson C.A., Carr A., Benson C., Carr A., Currier J.S., Dube M.P., Gerber J.G., Grinspoon S.K., Grunfeld C., Kotler D.P., Mulligan K., Powderly W.G., and Saag M.S. Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: Recommendations of an International AIDS Society-USA panel. J Acquir Immune Defic Syndr 31 (2002) 257-275
28. Schwenk A. Methods of assessing body shape and composition in HIV-associated lipodystrophy. Curr Opin Infect Dis 15 (2002) 9-16
29. Yang Y., Zhu W.D., and Paton N.I. Comparison of dual-energy X-ray absorptiometry machines for measuring fat distribution changes of HIV-associated lipodystrophy. Antivir Ther 9 (2004) 771-778
30. Yoshizumi T., Nakamura T., Yamane M., Islam A.H., Menju M., Yamasaki K., Arai T., Kotani K., Funahashi T., Yamashita S., and Matsuzawa Y. Abdominal fat: Standardized technique for measurement at CT. Radiology 211 (1999) 283-286